Insulin Efsitora vs. Degludec for type 2 diabetes
This Medudy course is a video tutorial for physicians on the topic of "Insulin Efsitora vs Degludec in type 2 diabetes". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Insulin Efsitora is a newly developed basal insulin for once-weekly use. The data [...]
Secondary antidiabetics in early pregnancy
This Medudy course is a video tutorial for physicians on the topic of "Secondary antidiabetics in early pregnancy". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. The use of non-insulin-based second-line antidiabetic agents in pregnant women with type 2 diabetes is increasing. However, [...]
Lixisenatide in the early Parkinson's stage
This Medudy course is a video tutorial for physicians on the topic of "Lixisenatide in Early Parkinson's Disease", in which we summarize the latest and most important clinical studies for you. Interestingly, diabetes treatments like glucagon-like peptide-1 (GLP-1) receptor agonists, which increase GLP-1 levels, have been associated with a lower prevalence of Parkinson's disease. Lixisenatide, [...]
Risk score for the prognosis of acute renal failure after cisplatin administration
This Medudy course is a video tutorial for physicians on the topic of "Risk score for the prognosis of acute renal failure after cisplatin administration". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Cisplatin is a powerful chemotherapeutic agent that is commonly used to treat various types of cancer [...].
Benralizumab for eosinophilic esophagitis
This Medudy course is a video tutorial for physicians on the topic of "Benralizumab in eosinophilic esophagitis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Current treatment options for eosinophilic esophagitis are of limited efficacy. This highlights the need for [...]
MoonRISe-1: TAR-210 for non-muscle-invasive bladder cancer
This Medudy course is a video tutorial for physicians on "MoonRISe-1: TAR-210 for non-muscle invasive bladder cancer". Despite the availability of treatment options for patients with intermediate-risk non-muscle-invasive bladder cancer, recurrence rates remain high. The Moonrise-1 trial is investigating TAR-210, an intravesical drug delivery system that enables the sustained release of erdafitinib directly into the bladder. [...]
Muscle-invasive bladder carcinoma
Prof. Dr. med. Günter Niegisch
Insulin Efsitora vs. Degludec for type 1 diabetes
This Medudy course is a video tutorial for physicians on the topic of "Insulin Efsitora vs Insulin Degludec in type 1 diabetes". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Insulin Efsitora alfa is a basal insulin that is administered once a week. The efficacy [...]
Patisiran for transthyretin amyloidosis with cardiomyopathy
This Medudy course is a video tutorial for physicians on the topic "Patisiran in transthyretin amyloidosis with cardiomyopathy". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Transthyretin amyloidosis (ATTR) is a progressive disease caused by misfolded transthyretin, which manifests as a [...]
Semaglutide for obesity and knee osteoarthritis
This Medudy course is a video tutorial for physicians on the topic of "Semaglutide in obesity and knee osteoarthritis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Obesity is considered a major risk factor for knee osteoarthritis. Current guidelines therefore recommend weight reduction and increased physical [...]